Creative Diagnostics Introduces the Launch of Beta Actin Antibody

As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently expanded antibody portfolio with the launch of a series of beta actin antibody for ICC/IF, WB, and IHC-P. These new products are only for research use, and are not intended for diagnostic use.

Creative Diagnostics offers primary antibodies to multiple forms of virtually every protein in the proteome, and secondary antibodies that are available targeting all common research species and are conjugated with multiple types of enzymes and fluorescence, as well as control antibodies to make sure researchers generating data with confidence. Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. The anti beta actin monoclonal antibodies can be used to detect beta-actin, which is one of six different actin proteins.

For example, Anti-ACTB monoclonal antibody (DCABH-10282), one of the products included in this release, is mouse anti-Human ACTB monoclonal antibody that can be used for ICC/IF, WB, and IHC-P. This antibody can specifically recognize beta actin in tissues or species through immunoblotting, immunofluorescence staining of cultured cell lines, and immunohistochemistry.

"Creative Diagnostics is committed to developing and delivering high quality research tools and solutions to the life science community, and we're so glad to advance our clients' scientific discoveries and accelerate their next breakthrough by continuously offering such monoclonal antibodies. Our mouse monoclonal antibody to beta actin is now available for global researchers, and more improved antibodies and services will be offered to meet the unmet needs of scientists working in basic research and development." said Prof. Mike Knuth, M.D., the chief scientific officer of R&D department of Creative Diagnostics.

"Creative diagnostics offers a wide range of high quality antibodies validated for use in multiplexed assays. Beta actin antibodies are highly complementary to our existing antibody offerings and will further help us meet the continuing demands from our customers for high quality antibodies. We'll continue to work to develop more antibody products and customized services for researchers in the future." said Dr. Jessica Waldorf, chief scientific officer of R&D department of Creative Diagnostics.

If you want to know more information about beta actin antibodies or other research materials, please visit Creative Diagnostics at https://www.creative-diagnostics.com/.

About Creative Diagnostics

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components and critical assay reagents. It also provides contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. It aims to provide a trusted source for all researchers' assay development and manufacturing needs.